A Study of EPEG in Beta Thalassemia Patients
Clinical trial NCT02950857 · COMPLETED
Trial details
- NCT number
- NCT02950857
- Sponsor
- Prolong Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-28
- Primary completion
- 2017-09-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.